This pathway is thought to be distinct from the conventional adenoma-carcinoma pathway, where adenomas progress to invasive colorectal carcinomas through the influence of several genetic alterations including adenomatous polyposis coli (APC) and KRAS mutations [4, 6, 10, 11, 14, 15]. Here, KRAS is linked to adenoma.